In a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?
Shikhar Khurana, MD
Advertisement
PGY 1 Resident Physician, Sidney Kimmel Medical College of Thomas Jefferson University
Articles by Shikhar Khurana, MD
Advertisement
Latest Updated Articles
Navigating Treatment Decision-Making in Multiple SclerosisPublished: March 24th 2024 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency
2
New Study to Assess Complement Inhibitor Iptacopan in Generalized Myasthenia Gravis
3
Evolving Landscape of Myasthenia Gravis Treatment and Unmet Needs: Leila Darki, MD
4
Exploring Long-Term Efficacy of Inebilizumab in Phase 3 Myasthenia Gravis Trial: Richard Nowak, MD, MS
5
